{
  "id": "biomarker-compliance-by-payer",
  "display_name": "Biomarker Testing by Payer",
  "cohort": "Biomarker Testing, by Payer (2024–2025)",
  "insight_type": "Precision Medicine Utilization",
  "summary": "Testing compliance shows strong payer variation: Commercial 84%, Medicare 72%, and Medicaid 58%. Solving authorization barriers could generate $280,000 in annual value.",
  "chart": {
    "type": "bar",
    "unit": "payer",
    "data": [
      { "name": "Commercial", "value": 84, "gap": 9, "highlight": false },
      { "name": "Medicare", "value": 72, "gap": -3, "highlight": false },
      { "name": "Medicare Advantage", "value": 68, "gap": -7, "highlight": false },
      { "name": "Medicaid", "value": 58, "gap": -17, "highlight": true },
      { "name": "Exchange", "value": 64, "gap": -11, "highlight": true },
      { "name": "VA/Tricare", "value": 76, "gap": 1, "highlight": false }
    ],
    "benchmark": 75,
    "nccn_target": 90
  },
  "financial_impact": {
    "annual_opportunity": "$280,000/year",
    "math": "$280,000/year = 14% avg testing gap (lagging payers) × 58 patients × $34,500 precision therapy value"
  },
  "clinical_impact": {
    "description": "Reducing payer-based disparities in biomarker testing improves care equity and outcomes.",
    "metrics": [
      {
        "type": "PFS",
        "value": "+5.1 months",
        "description": "Improved progression-free survival with matched therapies"
      },
      {
        "type": "OS",
        "value": "+7.8 months",
        "description": "Overall survival benefit with biomarker-guided treatment"
      },
      {
        "type": "ORR",
        "value": "+32%",
        "description": "Higher objective response rate with targeted therapies"
      },
      {
        "type": "TFT",
        "value": "-42%",
        "description": "Reduced time from testing to treatment"
      },
      {
        "type": "CE",
        "value": "+28%",
        "description": "Improved care equity across payer types"
      }
    ],
    "quantitative": "+7.8 months OS"
  },
  "peer_comparison": {
    "description": "Top-performing practices achieve >80% biomarker testing compliance across all payer types through streamlined prior authorization processes.",
    "peer_benchmark": 80,
    "financial_impact": {
      "annual_opportunity": "$345,000/year",
      "math": "$345,000/year = $280,000 direct therapy value + $65,000 operational efficiency"
    },
    "action_steps": [
      {
        "text": "Implement dedicated prior authorization team for biomarker testing",
        "icon": "users"
      },
      {
        "text": "Develop payer-specific biomarker testing pathways",
        "icon": "document"
      },
      {
        "text": "Create automated prior authorization submission tool",
        "icon": "cog"
      },
      {
        "text": "Negotiate biomarker testing agreements with key payers",
        "icon": "handshake"
      }
    ]
  },
  "weighted_score": 92,
  "action_steps": [
    {
      "text": "Implement dedicated prior authorization team for Medicaid patients",
      "icon": "users"
    },
    {
      "text": "Deploy automated payer-specific testing protocols",
      "icon": "cog"
    },
    {
      "text": "Develop financial assistance program for testing",
      "icon": "cash"
    },
    {
      "text": "Create payer liaison role for complex biomarker cases",
      "icon": "user"
    }
  ],
  "suggestions": [
    {
      "text": "Analyze denial patterns by payer and test type",
      "icon": "search"
    },
    {
      "text": "Evaluate preauthorization success rates by staff member",
      "icon": "chart"
    }
  ],
  "drilldowns": [
    {
      "label": "Medicaid Detail",
      "cohort": "Medicaid Biomarker Testing",
      "jsonFile": "biomarker-compliance-medicaid.json",
      "drilldownLevel": 2
    },
    {
      "label": "By Testing Method",
      "cohort": "Biomarker Testing by Method",
      "jsonFile": "biomarker-compliance-by-method.json",
      "drilldownLevel": 1
    },
    {
      "label": "By Cancer Type",
      "cohort": "Biomarker Testing by Cancer Type",
      "jsonFile": "biomarker-compliance-by-cancer.json",
      "drilldownLevel": 1
    },
    {
      "label": "Overall Compliance",
      "cohort": "Biomarker Testing Compliance",
      "jsonFile": "biomarker-compliance.json",
      "drilldownLevel": 0
    }
  ]
} 